Synthesis and biological evaluation of irreversible inhibitors of aldose reductaseARES, J. J; KADOR, P. F; MILLER, D. D et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 11, pp 2384-2389, issn 0022-2623Article

EFFECTS OF ALDOSE REDUCTASE INHIBITOR TREATMENT IN DIABETIC POLYNEUROPATHY. A CLINICAL AND NEUROPHYSIOLOGICAL STUDYFAGIUS J; JAMESON S.1981; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1981; VOL. 44; NO 11; PP. 991-1001; BIBL. 59 REF.Article

CLINICAL TRIAL OF AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHYHANDELSMAN DJ; TURTLE JR.1981; DIABETES (N.Y.); ISSN 0012-1797; USA; DA. 1981; VOL. 30; NO 6; PP. 459-464; BIBL. 30 REF.Article

Proceedings/Symposium on aldose reductase inhibition and late, complications of diabetes. International diabetes federation polyol pathway workshop, Madrid 23 September 1985WARD, J. D; BENFIELD, P. Ed.Drugs (Basel). 1986, Vol 32, issn 0012-6667, 55 p., suppl. 2Conference Proceedings

EFFECT OF ALRESTATIN SODIUM ON GLUCOSE-STIMULATED INSULIN SECRETION IN THE FASTED ANAESTHETIZED RATKOBRIC M; LIPPMAN W.1978; HORMONE METABOL. RES.; DEU; DA. 1978; VOL. 10; NO 6; PP. 495-500; BIBL. 41 REF.Article

Aldose reductase inhibitors in the treatment of diabetic neuropathy : a review of the rationale and clinical evidenceMASSON, E. A; BOULTON, A. J. M.Drugs (Basel). 1990, Vol 39, Num 2, pp 190-202, issn 0012-6667Article

ALRESTATIN: GASTRIC ACID ANTISECRETORY-ANTIULCER ACTIVITY IN THE RATLIPPMANN W; SEETHALER K; BORELLA LE et al.1978; DIGESTION; CHE; DA. 1978; VOL. 18; NO 1-2; PP. 35-44; BIBL. 30 REF.Article